46 Ken Fisher Charles River Laboratories International Trades
Ken Fisher's position in Charles River Laboratories International is currently worth $32.8 Million. That's 0.01% of their equity portfolio (256th largest holding). The first Charles River Laboratories International trade was made in Q3 2013. Since then Ken Fisher bought shares eighteen more times and sold shares on 27 occasions. The stake costed the investor $20.9 Million, netting the investor a gain of 57% so far.
News about Charles River Laboratories International Inc. and Ken Fisher
Pyrogen Testing Market Analysis Report | Future Development, Post Pandemic Impact & Top Key Players - Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Merck KGaA, Charles River Laboratories International, Inc., and GenScript
Transparency Market Research (TMR) has published a new report titled, Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and For...
Cell and Gene Therapy Manufacturing Services Market Stunning $13 Bn by 2028| Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation
Cell and Gene Therapy Manufacturing Services Market is projected to thrive at $13.8 Bn at CAGR +12% by the timeframe of 2021-28. Cell therapy manufacturing, ...
Monocyte Activation Tests Market 2021 Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast to 2028| Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories International, Inc
QY Reports has released a new The Global Monocyte Activation Tests Market report provides information on market size, share, trends, growth, cost structure, ...
Cell & Gene Therapy Manufacturing Services Market Worldwide Survey On Product Need 2030 | Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza
Cell & Gene Therapy Manufacturing Services Market: Overview The cell & gene therapy manufacturing services market is majorly driven by rising agreements and ...